Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Macular Edema(DME)”

264 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 264 results

Early research (Phase 1)Study completedNCT03511898
What this trial is testing

Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Who this might be right for
Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema
ThromboGenics 12
Large-scale testing (Phase 3)Study completedNCT00605280
What this trial is testing

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Who this might be right for
Macular Edema Associated With Diabetes Mellitus
Pfizer 317
Post-approval studies (Phase 4)UnknownNCT04038125
What this trial is testing

Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME

Who this might be right for
Diabetic Macular EdemaDiabetic RetinopathyRetinal Ischemia
Retina Macula Specialists of Miami, LLC 20
Early research (Phase 1)Study completedNCT03835884
What this trial is testing

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Aerie Pharmaceuticals 18
Post-approval studies (Phase 4)Study completedNCT02299336
What this trial is testing

Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial

Who this might be right for
Diabetic Macular Edema
Greater Houston Retina Research 60
Post-approval studies (Phase 4)Study completedNCT03780361
What this trial is testing

Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)

Who this might be right for
Diabetic Macular Edema
Hyewon Chung 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07199777
What this trial is testing

A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

Who this might be right for
Diabetic Macular EdemaDME
SciNeuro 60
Not applicableUnknownNCT04601675
What this trial is testing

Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

Who this might be right for
Macular Edema
He Eye Hospital 100
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Testing effectiveness (Phase 2)Active Not RecruitingNCT05930561
What this trial is testing

4D-150 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaDiabetic Retinopathy
4D Molecular Therapeutics 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459829
What this trial is testing

Study of CU06-1004 in Patients With Daibetic Macular Edema

Who this might be right for
DMEDiabetic Macular EdemaDiabetic Macular Edema (DME)
Curacle Co., Ltd. 156
Testing effectiveness (Phase 2)Ended earlyNCT05063734
What this trial is testing

Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Who this might be right for
Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema
Oxurion 16
Not applicableStudy completedNCT02811692
What this trial is testing

Study for Collection of Aflibercept Data in Routine Practice

Who this might be right for
Eye Diseases
Bayer 425
Post-approval studies (Phase 4)Study completedNCT04411693
What this trial is testing

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
The Cleveland Clinic 23
Large-scale testing (Phase 3)Active Not RecruitingNCT07449936
What this trial is testing

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Who this might be right for
Diabetic Macular EdemaDMEDiabetic Macular Edema (DME)
EyePoint Pharmaceuticals, Inc. 240
Not applicableLooking for participantsNCT06929507
What this trial is testing

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Who this might be right for
Renal Function DisorderDiabetic Macular Edema (DME)Neovascular Age Related Macular Degeneration
University Hospital, Alexandroupolis 60
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Post-approval studies (Phase 4)Study completedNCT01309451
What this trial is testing

Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Maturi, Raj K., M.D., P.C. 40
Large-scale testing (Phase 3)Study completedNCT04739306
What this trial is testing

Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
Celltrion 348
Early research (Phase 1)WithdrawnNCT02842541
What this trial is testing

Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Eleven Biotherapeutics
Next Page